The Cerbat Gem
2 days ago
TipRanks
2 days ago
Investor's Business Daily
2 days ago
24/7 Wall St.
2 days ago
Ars Technica
2 days ago
MarketBeat
2 days ago
MarketBeat
2 days ago
MarketBeat
2 days ago
MarketBeat
2 days ago
MarketBeat
2 days ago
MarketBeat
2 days ago
MarketBeat
2 days ago
Investor's Business Daily
2 days ago
MarketBeat
2 days ago
MarketBeat
2 days ago

Lyntris (NYSE:LYNX) Upgraded to Strong-Buy at Evercore

MarketBeat
2 days ago

NIKE (NYSE:NKE) Rating Lowered to "Hold" at Robert W. Baird

MarketBeat
2 days ago

TC Energy (TSE:TRP) Upgraded at TD Securities

MarketBeat
2 days ago

V.F. (NYSE:VFC) Rating Lowered to Hold at Robert W. Baird

MarketBeat
2 days ago

HSBC (NYSE:HSBC) Stock Rating Lowered by Keefe, Bruyette & Woods

MarketBeat
2 days ago

Only 8% of Billionaires Fully Inherited Their Money. Here's How the Rest Got Rich

24/7 Wall St.
2 days ago

Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules

GuruFocus
2 days ago

Philadelphia Turns Up the Heat with its First-Ever Sweet Heat Cream Cheese in the United States in Partnership with Mike's Hot Honey®

GuruFocus
2 days ago

Kwik Fill Selects PAR Technology to Power Its Guest Engagement Strategy and Accelerate AI-Driven Innovation

GuruFocus
2 days ago

Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia

GuruFocus
2 days ago

CI Global Asset Management Launches Global Small/Mid-Cap and International Growth Equity Mandates, Providing New Diversification Options for Mutual Fund and ETF Investors

GuruFocus
2 days ago

Kinaxis Advances Operational Orchestration Vision with Agentic AI at Kinexions EMEA 2026

GuruFocus
2 days ago

Deep Fission Publishes DOE-Approved Nuclear Safety Design Agreement for Gravity™ Pilot Reactor, Demonstrating Commitment to Transparency

GuruFocus
2 days ago

Tech Worker, 37, Built $15M Fortune Now 'I Felt Lost Doing Nothing'

Benzinga
2 days ago

Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease

GuruFocus
2 days ago